Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.

Frontiers in immunology - 1 Jan 2021

Zhou Xiaogang, Liu Yu, Xiang Jing, Wang Yuntao, Wang Qiqian, Xia Jianling, Chen Yunfei, Bai Yifeng

Abstract excerpt

Immune checkpoint inhibitors (ICIs) have made breakthrough progress in the treatment of various malignant tumors. However, only some patients receiving ICIs obtain long-lasting clinical effects, and some patients still do not achieve remission. Improving the treatment benefits of this part of the population has become a concern of clinicians. IL-1 signaling plays an important role in the tumor microenvironment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colonic Neoplasms

Share to Gene Expression Regulation, Neoplastic

Share to Immunotherapy

Share to Interleukin-1

Share to Survival Analysis

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 34367132
DOI: 10.3389/fimmu.2021.665002
PMCID: PMC8344046

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.PMID 34367132Read ↗

Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma.Semantic proximity Read ↗

The Role of CXCL10 in Prognosis of Patients with Colon Cancer and Tumor Microenvironment RemodelingSemantic proximity Read ↗

Identification and Validation of Immune Molecular Subtypes and Immune Landscape Based on Colon Cancer CohortSemantic proximity Read ↗

Comprehensive Analysis of Subtype-Specific Molecular Characteristics of Colon Cancer: Specific Genes, Driver Genes, Signaling Pathways, and Immunotherapy ResponsesSemantic proximity Read ↗

Integrating tumor mutational burden and transcriptome expression into prediction of immune checkpoint inhibitor response and prognosis of patients with colon cancer.Semantic proximity Read ↗

Prognostic value of tumor immune cell infiltration patterns in colon adenocarcinoma based on systematic bioinformatics analysisSemantic proximity Read ↗

Comprehensive Analysis Identifies PI3K/Akt Pathway Alternations as an Immune-Related Prognostic Biomarker in Colon Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitor Treatment.Semantic proximity Read ↗

Two immune-enhanced molecular subtypes differ in inflammation, immune checkpoints, mutations, and prognostic outcome in stage I-II colonic carcinoma.Semantic proximity Read ↗

Multi-omics analysis of the potential of MACC1 as a biomarker and therapeutic target for colonic adenocarcinomaSemantic proximity Read ↗

Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironmentSemantic proximity Read ↗

Two immune-enhanced molecular subtypes differ in inflammation, immune checkpoints, mutations and outcome in Stage I-II colonic carcinoma.Semantic proximity Read ↗

Alteration in the Immune Microenvironment Based on APC Status in MSS/pMMR Colon Cancer Data Retrieved from TCGASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.